Results 221 to 230 of about 61,456 (351)
Commentary:The association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's disease - Authors' reply [PDF]
Chan, S.S.M., Hart, A.R.
core +1 more source
A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn Disease
Arie Levine +9 more
openalex +1 more source
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant +3 more
wiley +1 more source
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. [PDF]
Rieder F +20 more
europepmc +1 more source
ABSTRACT Selective androgenic receptor modulators (SARMs) have similar properties to anabolic steroids but bind to androgen receptors in a tissue‐specific manner. Studies have investigated the benefits of SARMs in promoting bone and muscle growth while limiting the adverse effects of androgenic stimulation of other organs.
David J. Katibian +3 more
wiley +1 more source
Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review. [PDF]
Chen S +5 more
europepmc +1 more source
Posttraining survey of recent pediatric gastroenterology fellowship graduates
Abstract Objectives The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Training Committee conducted a survey of recent fellowship graduates to assess their confidence in procedure performance, disease management, practice habits, and satisfaction with mentorship.
Christopher J. Moran +12 more
wiley +1 more source
First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitis. [PDF]
Supovec E +5 more
europepmc +1 more source

